The UK has approved the use of Pfizer-Biotech vaccine for children 12-15 years of age.
It is safe and effective in this age group and the benefits outweigh the risks.
The MHRA says it has conducted a rigorous review of the benefits of vaccination during adolescence.
The Pfizer vaccine is already approved for people 16 years of age and older.
